z-logo
open-access-imgOpen Access
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
Author(s) -
Mingzhao Xing,
Ali S. Alzahrani,
Kathryn A. Carson,
Young Kee Shong,
Tae Yong Kim,
David Viola,
Rossella Elisei,
Běla Bendlová,
Linwah Yip,
Caterina Mian,
Federica Vianello,
R. Michael Tuttle,
Eyal Robenshtok,
James A. Fagin,
Efisio Puxeddu,
Laura Fugazzola,
Agnieszka Czarniecka,
Barbara Jarząb,
Christine J. O’Neill,
Mark Sywak,
Alfred K. Lam,
Garcilaso RiescoEizaguirre,
Pilar Santisteban,
Hirotaka Nakayama,
Roderick CliftonBligh,
Giovanni Tallini,
Elizabeth H. Holt,
Vlasta Sýkorová
Publication year - 2014
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2014.56.8253
Subject(s) - medicine , papillary thyroid cancer , interquartile range , hazard ratio , v600e , thyroid cancer , mutation , retrospective cohort study , gastroenterology , cancer , thyroid , oncology , confidence interval , genetics , gene , biology
To investigate the prognostic value of BRAF V600E mutation for the recurrence of papillary thyroid cancer (PTC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom